Celgene Corp. (CELG) Financials Nov 18, 2014, 7:51
Post# of 250665
Posted On: 11/18/2014 9:55:06 PM
Celgene Corp. (CELG) Financials Nov 18, 2014, 7:51 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Celgene Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.73B 3.58B 4.84B 5.43B 6.48B
Cost of Goods Sold (COGS) incl. D&A 299.29M 509.75M 715.09M 493.62M 603.2M
COGS excluding D&A 173.22M 250.66M 352.23M 210.18M 229.1M
Depreciation & Amortization Expense 126.07M 259.09M 362.85M 283.45M 374.1M
Depreciation 41.68M 54.23M 71.15M 84.87M 96.9M
Amortization of Intangibles 84.39M 204.86M 291.7M 198.57M 277.2M
Gross Income 2.43B 3.07B 4.13B 4.93B 5.88B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.55B 2.08B 2.71B 2.98B 3.91B
Research & Development 794.22M 1.13B 1.48B 1.6B 2.23B
Other SG&A 753.83M 950.63M 1.23B 1.37B 1.68B
Other Operating Expense 0 0 0 0 0
Unusual Expense (6.08M) 47.3M (56.34M) 281.37M 103.7M
EBIT after Unusual Expense 6.08M (47.3M) 56.34M (281.37M) (103.7M)
Non Operating Income/Expense 16.93M 60.13M (22.71M) 56.67M (109.9M)
Non-Operating Interest Income 76.79M 25.16M 18.46M 15.26M 29.3M
Equity in Affiliates (Pretax) (1.1M) (1.93M) (2.8M) - 0
Interest Expense 1.97M 12.63M 48.2M 69.76M 119.6M
Gross Interest Expense 1.97M 12.63M 48.2M 69.76M 119.6M
Interest Capitalized 0 0 0 0 0
Pretax Income 975.7M 1.01B 1.42B 1.68B 1.67B
Income Tax 198.96M 132.42M 102.07M 225.31M 215.5M
Income Tax - Current Domestic 200.59M 194.66M 134.06M 69.7M 398M
Income Tax - Current Foreign 25.31M 41.69M 53.83M 55.41M 64.1M
Income Tax - Deferred Domestic (25.72M) (99.58M) (67.17M) 107.35M (245.1M)
Income Tax - Deferred Foreign (1.22M) (4.34M) (18.66M) (7.15M) (1.5M)
Income Tax Credits - 0 0 - 0
Equity in Affiliates - 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 776.75M 880.19M 1.32B 1.46B 1.45B
Minority Interest Expense 0 (320,000) (694,000) 0 0
Net Income 776.75M 880.51M 1.32B 1.46B 1.45B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 776.75M 880.51M 1.32B 1.46B 1.45B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 776.75M 880.51M 1.32B 1.46B 1.45B
EPS (Basic) 0.85 0.95 1.45 1.69 1.75
Basic Shares Outstanding 918.61M 924.6M 910.7M 861.85M 827.6M
EPS (Diluted) 0.83 0.94 1.43 1.65 1.69
Diluted Shares Outstanding 934.71M 939.03M 925.5M 881.59M 860.6M
EBITDA 1.01B 1.25B 1.78B 2.24B 2.34B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Celgene Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.73B 3.58B 4.84B 5.43B 6.48B
Cost of Goods Sold (COGS) incl. D&A 299.29M 509.75M 715.09M 493.62M 603.2M
COGS excluding D&A 173.22M 250.66M 352.23M 210.18M 229.1M
Depreciation & Amortization Expense 126.07M 259.09M 362.85M 283.45M 374.1M
Depreciation 41.68M 54.23M 71.15M 84.87M 96.9M
Amortization of Intangibles 84.39M 204.86M 291.7M 198.57M 277.2M
Gross Income 2.43B 3.07B 4.13B 4.93B 5.88B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.55B 2.08B 2.71B 2.98B 3.91B
Research & Development 794.22M 1.13B 1.48B 1.6B 2.23B
Other SG&A 753.83M 950.63M 1.23B 1.37B 1.68B
Other Operating Expense 0 0 0 0 0
Unusual Expense (6.08M) 47.3M (56.34M) 281.37M 103.7M
EBIT after Unusual Expense 6.08M (47.3M) 56.34M (281.37M) (103.7M)
Non Operating Income/Expense 16.93M 60.13M (22.71M) 56.67M (109.9M)
Non-Operating Interest Income 76.79M 25.16M 18.46M 15.26M 29.3M
Equity in Affiliates (Pretax) (1.1M) (1.93M) (2.8M) - 0
Interest Expense 1.97M 12.63M 48.2M 69.76M 119.6M
Gross Interest Expense 1.97M 12.63M 48.2M 69.76M 119.6M
Interest Capitalized 0 0 0 0 0
Pretax Income 975.7M 1.01B 1.42B 1.68B 1.67B
Income Tax 198.96M 132.42M 102.07M 225.31M 215.5M
Income Tax - Current Domestic 200.59M 194.66M 134.06M 69.7M 398M
Income Tax - Current Foreign 25.31M 41.69M 53.83M 55.41M 64.1M
Income Tax - Deferred Domestic (25.72M) (99.58M) (67.17M) 107.35M (245.1M)
Income Tax - Deferred Foreign (1.22M) (4.34M) (18.66M) (7.15M) (1.5M)
Income Tax Credits - 0 0 - 0
Equity in Affiliates - 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 776.75M 880.19M 1.32B 1.46B 1.45B
Minority Interest Expense 0 (320,000) (694,000) 0 0
Net Income 776.75M 880.51M 1.32B 1.46B 1.45B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 776.75M 880.51M 1.32B 1.46B 1.45B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 776.75M 880.51M 1.32B 1.46B 1.45B
EPS (Basic) 0.85 0.95 1.45 1.69 1.75
Basic Shares Outstanding 918.61M 924.6M 910.7M 861.85M 827.6M
EPS (Diluted) 0.83 0.94 1.43 1.65 1.69
Diluted Shares Outstanding 934.71M 939.03M 925.5M 881.59M 860.6M
EBITDA 1.01B 1.25B 1.78B 2.24B 2.34B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)